Concourse Financial Group Securities’s Adaptive Biotechnologies ADPT Stock Holding History

Concourse Financial Group Securities’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200	Closed	-$1.32K	–	2304
2023 Q2	$1.34K	Hold	200	–	–	﹤0.01%	2084
2023 Q1	$1.77K	Hold	200	–	–	﹤0.01%	2077
2022 Q4	$1.53K	Buy	+200	New	+$1.56K	﹤0.01%	2086
2022 Q3	–	Sell	-200	Closed	-$1.88K	–	1993
2022 Q2	$2K	Hold	200	–	–	﹤0.01%	1997
2022 Q1	$3K	Sell	200 -492	-71%	-$7.74K	﹤0.01%	1933
2021 Q4	$19K	Buy	692 +484	+233%	+$14.8K	﹤0.01%	1651
2021 Q3	$7K	Hold	208	–	–	﹤0.01%	1966
2021 Q2	$8K	Sell	208 -600	-74%	-$23.3K	﹤0.01%	1918
2021 Q1	$33K	Buy	808 +600	+288%	+$32.5K	﹤0.01%	1380
2020 Q4	$12K	Buy	208 +8	+4%	+$413	﹤0.01%	1621
2020 Q3	$10K	Hold	200	–	–	﹤0.01%	1568
2020 Q2	$10K	Hold	200	–	–	﹤0.01%	1487
2020 Q1	$6K	Hold	200	–	–	﹤0.01%	1579
2019 Q4	$6K	Hold	200	–	–	﹤0.01%	1563
2019 Q3	$6K	Buy	+200	New	+$8.16K	﹤0.01%	1255

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Concourse Financial Group Securities's ADPT Position: Q3 2023 in Review

Concourse Financial Group Securities sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 200 shares — an estimated $1.32K sold.

Concourse Financial Group Securities first reported a position in ADPT in Q3 2019 and held it in 15 quarters. The position peaked at $33K in Q1 2021. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

Concourse Financial Group Securities reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
Concourse Financial Group Securities sold 200 Adaptive Biotechnologies shares in Q3 2023, an estimated $1.32K.
Concourse Financial Group Securities first reported a position in Adaptive Biotechnologies in Q3 2019 and held it in 15 quarters.
Concourse Financial Group Securities's Adaptive Biotechnologies position peaked at $33K in Q1 2021.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on Concourse Financial Group Securities's 13F filing for Q3 2023, filed 25 Oct 2023.